A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for the Prevention of Yellow Fever, and of an Investigational Vaccine for the Prevention of Rabies, in Healthy Adults

NCT06998004 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

112

Enrollment

INDUSTRY

Sponsor class

Conditions

Yellow Fever
Rabies

Interventions

BIOLOGICAL: AVX70120 low dose level
BIOLOGICAL: AVX70120 middle dose level
BIOLOGICAL: AVX70120 high dose level
BIOLOGICAL: AVX70481 low dose level
BIOLOGICAL: AVX70481 middle dose level
BIOLOGICAL: AVX70481 high dose level
OTHER: Placebo

Sponsor

AstriVax Therapeutics